Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 12/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.40 |
| ▸ | PRKCG | P05129 | 2/20 | 0.40 |
| ▸ | PRKCB | P05771 | 2/20 | 0.40 |
| ▸ | PRKCA | P17252 | 2/20 | 0.40 |
| ▸ | PRKCH | P24723 | 2/20 | 0.40 |
| ▸ | PRKCI | P41743 | 2/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.40 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.40 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25421037 | 0.89 | ENPP2 (0.59) | ENPP2LPAR2PRKD3PRKCGPRKCB | |
| SCHEMBL25217057 | 0.89 | ENPP2 (0.59) | ENPP2LPAR2PRKD3PRKCGPRKCB | |
| SCHEMBL25215389 | 0.89 | ENPP2 (0.59) | ENPP2LPAR2PRKD3PRKCGPRKCB | |
| SCHEMBL25422178 | 0.89 | ENPP2 (0.59) | ENPP2LPAR2PRKD3PRKCGPRKCB | |
| SCHEMBL25421986 | 0.89 | ENPP2 (0.59) | ENPP2LPAR2PRKD3PRKCGPRKCB | |
| SCHEMBL25421996 | 0.82 | ENPP2 (0.64) | ENPP2LPAR2 | |
| SCHEMBL25624689 | 0.82 | ENPP2 (0.64) | ENPP2LPAR2 | |
| SCHEMBL25421999 | 0.82 | ENPP2 (0.64) | ENPP2LPAR2 | |
| SCHEMBL25271617 | 0.80 | EPHX1 (0.35) | EPHX1ALDH1A1 | |
| SCHEMBL25228822 | 0.79 | EPHX1 (0.34) | EPHX1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444705-A1 | GLYCEROL ACETAL SULFATE AND SULFONATE SURFACTANTS | The Procter & Gamble Company (US) | 2024-10-16 | — | — | EP | claimed |
| CN-118355002-A | Glycerol acetal sulfate and sulfonate surfactants | 宝洁公司 | 2024-07-16 | — | — | CN | claimed |
| WO-2023107877-A1 | GLYCEROL ACETAL SULFATE AND SULFONATE SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-15 | — | — | WO | claimed |
| US-20230174895-A1 | GLYCEROL ACETAL SULFATE AND SULFONATE SURFACTANTS | THE PROCTER & GAMBLE COMPANY | 2023-06-08 | — | — | US | claimed |
| EP-4194533-A1 | LIQUID HAND DISHWASHING DETERGENT COMPOSITION | The Procter & Gamble Company (US) | 2023-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174895-A1 | GLYCEROL ACETAL SULFATE AND SULFONATE SURFACTANTS | GK, GMDS, SGMS1 | ENPP2 1315/4885LPAR2 383/4885EPHX1 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.